• Policy
• Will Paxlovid soon be reimbursed in Korea?
• by Lee, Tak-Sun Aug 19, 2024 05:47am

• Policy
• KDCA operates Public-Private Council for COVID-19 response
• by Kang, Hye-Kyung Aug 16, 2024 05:56am

• Company
• Twice-yearly Uplizna enters last stage to reimb in KOR
• by Eo, Yun-Ho Aug 16, 2024 05:56am

• Company
• OraTicx signs a distribution deal with U.S.-based Stratum
• by Son, Hyung-Min Aug 16, 2024 05:56am

• Policy
• KDCA 'COVID-19 drug supply will be stabilized within August'
• by Lee, Hye-Kyung Aug 16, 2024 05:55am

• Company
• K-Pharma speeds up marketing new drugs for bile duct cancer
• by Son, Hyung-Min Aug 16, 2024 05:55am

• Will Keytruda be reimb for its 17 indications in 2H?
• by Eo, Yun-Ho Aug 14, 2024 05:51am

• Company
• LG Chem begins Phase 2 trials for infant hexavalent vaccine
• by Hwang, Byung-woo Aug 14, 2024 05:51am

• Policy
• Gov’t raises service fee for difficult surgeries
• by Lee, Tak-Sun Aug 14, 2024 05:51am

• Policy
• Coinsurance rate for chronic diseases reduced from 30%→20%
• by Lee, Hye-Kyung Aug 14, 2024 05:51am